What it sells
AI Inference Platform for Drug Discovery
Business model breakdown
Buyer: who owns the budget?
UnverifiedComputational biology / protein engineering leads at biotech and pharma R&D (Premium and Enterprise plans are for companies).
Trigger: what makes them buy now?
UnverifiedAvoid deploying and maintaining open-source models like AlphaFold and RFdiffusion; need to design antibodies, enzymes, peptides and small molecules at scale.
Workflow: what inputs become what output?
Pick a hosted model (AlphaFold, RFdiffusion, MPNN, GROMACS and many others) via web UI or API, submit jobs, get results with no setup or literature review.
Economics: what it saves and how it charges
UnverifiedTiered SaaS (jobs per month, scale, security, custom model hosting); academic plan funnels users in.
Distribution: how it reaches customers
Self-serve free signup, API and MCP server, book-a-call for Premium and Enterprise, academic plan.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2024 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.